Viewing Study NCT04287881



Ignite Creation Date: 2024-05-06 @ 2:19 PM
Last Modification Date: 2024-10-26 @ 1:29 PM
Study NCT ID: NCT04287881
Status: COMPLETED
Last Update Posted: 2020-02-27
First Post: 2020-02-22

Brief Title: Methylenetetrahydrofolate Reductase Deficiency in Ischemic Stroke
Sponsor: Istanbul Medeniyet University
Organization: Istanbul Medeniyet University

Study Overview

Official Title: Investigation the Incidence of Methylenetetrahydrofolate Reductase Deficiency in Ischemic Cerebrovascular Diseases Presenting With Epileptic Seizures in Adults
Status: COMPLETED
Status Verified Date: 2020-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Adult onset epileptic seizures is rare and often associated with metabolic disorders drugs and intracranial pathologies such as ischemia hemorrhage or space-occupying lesions Methylenetetrahydrofolate reductase MTHFR deficiency is one of the reasons that cause epileptic seizures in adults and can be ignored MTHFR deficiency is an autosomal recessive disorder that results in hyperhomocysteinemia and causes a predisposition to venous and arterial thrombosis The incidence of the polymorphism is around 40 in some countries The aim of the retrospective study is to investigate the incidence of MTHFR deficiency in patients with adult-onset epileptic seizures
Detailed Description: Epileptic seizures that begin in adulthood seriously affect patients their relatives and the society in which they live financially and psychologically The etiology of epileptic seizures starting at adult age includes head trauma central nervous system infections intracranial lesions cerebrovascular events metabolic diseases and drugs While the causes of childhood epileptic seizures are generally considered idiopathic adult-onset epileptic seizures are almost always due to a pathological process Epileptic seizures in adults may be a symptom of ischemic stroke MTHFR deficiency is associated with raised homocysteine concentration in the body and increased risk of stroke 1 Studies have demonstrated that hyperhomocysteinemia is an independent risk factor for stroke 2

MTHFR is the key enzyme in remethylation of homocysteine to methionine MTHFR deficiency is an autosomal-recessive disease characterized by high homocysteine and low or normal methionine MTHFR deficiency can cause vascular thrombosis in adults at early age increased osteoporosis in elderly people deep vein thrombosis abortus during pregnancy and infertility in adult males In children it is associated with intrauterine growth retardation congenital heart diseases neural tube defects chromosome anomalies and hematologic tumors In any age group it might cause convulsions increased thrombosis risk with some anticonvulsants and with the use of nitrogen protoxide in surgeries and neuromotor retardation 3

The aim of this retrospective study is to investigate the incidence of MTHFR deficiency in patients presenting with adult-onset epileptic seizures and diagnosed as ischemic cerebrovascular disease as a result of diagnostic tests

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None